Model-based cost-effectiveness analysis of B-type natriuretic peptide-guided care in patients with heart failure

OBJECTIVE: Monitoring B-type natriuretic peptide (BNP) to guide pharmacotherapy might improve survival in patients with heart failure with reduced ejection fraction (HFrEF) or preserved ejection fraction (HFpEF). However, the cost-effectiveness of BNP-guided care is uncertain and guidelines do not u...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohiuddin, Syed, Reeves, Barnaby, Pufulete, Maria, Maishman, Rachel, Dayer, Mark, Macleod, John, McDonagh, Theresa, Purdy, Sarah, Rogers, Chris, Hollingworth, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223729/
https://www.ncbi.nlm.nih.gov/pubmed/28031211
http://dx.doi.org/10.1136/bmjopen-2016-014010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223729/
https://www.ncbi.nlm.nih.gov/pubmed/28031211
http://dx.doi.org/10.1136/bmjopen-2016-014010

Ejemplares similares